Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 17;369(16):1565-7.
doi: 10.1056/NEJMc1306509.

TREM2 and neurodegenerative disease

TREM2 and neurodegenerative disease

Priya Rajagopalan et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
At a 24-month follow-up scan, these 3D regression coefficient maps show brain volume differences in the temporal lobe associated with carrying the TREM2 risk allele. The risk allele carriers showed significantly accelerated brain atrophy from 1.4–3.3% in the statistical region of interest (FDR critical p = 0.0036; q = 0.05). Statistical tests were performed using permutation tests, which are robust in the presence of outliers and small sample sizes (see Supplement). The figure is shown in the radiological convention (left side of the image is the right hemisphere).

Comment in

  • TREM2 and neurodegenerative disease.
    Jonsson T, Stefansson K. Jonsson T, et al. N Engl J Med. 2013 Oct 17;369(16):1568-9. doi: 10.1056/NEJMc1306509. N Engl J Med. 2013. PMID: 24131183 No abstract available.

References

    1. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 Associated with the Risk of Alzheimer’s Disease. New England Journal of Medicine. 2013;368:107–116. - PMC - PubMed
    1. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer’s disease. New England Journal of Medicine. 2013;368:117–127. - PMC - PubMed
    1. Benitez BA, Cooper B, Pastor P, Jin S-C, Lorenzo E, Cervantes S, et al. TREM2 is associated with the risk of Alzheimer’s disease in Spanish population. Neurobiology of Aging. 2013 [epub, in press] - PMC - PubMed
    1. Hua X, Hibar DP, Ching CRK, Boyle CP, Rajagopalan P, Gutman BA, et al. Unbiased tensor-based morphometry: Improved robustness and sample size estimates for Alzheimer’s disease clinical trials. Neuroimage. 2012;66:648–61. - PMC - PubMed
    1. Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, et al. Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA: The Journal of the American Medical Association. 2003;289:2094–2103. - PubMed

Publication types